In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis

A large majority of new chemical entities and many existing drug molecules exhibit poor aqueous solubility, which may limit their potential use in developing drug formulations, with optimum bioavailability. One of the approaches to improve the solubility of a poorly water soluble drug and eventually its bioavailability is complexation with agents like humic acid (HA), fulvic acid (FA), β-cyclodextrin (β-CD), 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and caffeine (Caff). The current work emphasized at employing these agents to prepare different complexes and their in vitro/in vivo assessment. All the complexes evaluated for their complexation efficiency and authenticated by molecular modeling; conformational analysis, differential scanning calorimetry (DSC), X-ray diffraction (XRD), nuclear magnetic resonance (NMR) and mass spectroscopy. Furthermore, the complexes were assessed in an in vivo, rat vaginal model for their efficacy in treatment of vaginal candidiasis. Amongst the five tested complexes, fulvic acid-itraconazole complex yielded better solubility as well as in vivo efficacy and therefore may further be explored for developing a commercial formulation for treating vaginal candidiasis.

Saved in:
Bibliographic Details
Main Authors: Mirza,Mohammad Aamir, Rahman,Mohammad Akhlaquer, Talegaonkar,Sushama, Iqbal,Zeenat
Format: Digital revista
Language:English
Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1984-82502012000400020
record_format ojs
spelling oai:scielo:S1984-825020120004000202013-02-14In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasisMirza,Mohammad AamirRahman,Mohammad AkhlaquerTalegaonkar,SushamaIqbal,Zeenat Itraconazole/complexes Itraconazole/evaluation Itraconazole/complexes Itraconazole/in vitro Itraconazole/in vivo performance Vaginal candidiasis/treatment Drugs/solubility Drugs/formulation A large majority of new chemical entities and many existing drug molecules exhibit poor aqueous solubility, which may limit their potential use in developing drug formulations, with optimum bioavailability. One of the approaches to improve the solubility of a poorly water soluble drug and eventually its bioavailability is complexation with agents like humic acid (HA), fulvic acid (FA), β-cyclodextrin (β-CD), 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and caffeine (Caff). The current work emphasized at employing these agents to prepare different complexes and their in vitro/in vivo assessment. All the complexes evaluated for their complexation efficiency and authenticated by molecular modeling; conformational analysis, differential scanning calorimetry (DSC), X-ray diffraction (XRD), nuclear magnetic resonance (NMR) and mass spectroscopy. Furthermore, the complexes were assessed in an in vivo, rat vaginal model for their efficacy in treatment of vaginal candidiasis. Amongst the five tested complexes, fulvic acid-itraconazole complex yielded better solubility as well as in vivo efficacy and therefore may further be explored for developing a commercial formulation for treating vaginal candidiasis.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.48 n.4 20122012-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400020en10.1590/S1984-82502012000400020
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Mirza,Mohammad Aamir
Rahman,Mohammad Akhlaquer
Talegaonkar,Sushama
Iqbal,Zeenat
spellingShingle Mirza,Mohammad Aamir
Rahman,Mohammad Akhlaquer
Talegaonkar,Sushama
Iqbal,Zeenat
In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
author_facet Mirza,Mohammad Aamir
Rahman,Mohammad Akhlaquer
Talegaonkar,Sushama
Iqbal,Zeenat
author_sort Mirza,Mohammad Aamir
title In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
title_short In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
title_full In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
title_fullStr In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
title_full_unstemmed In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
title_sort in vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
description A large majority of new chemical entities and many existing drug molecules exhibit poor aqueous solubility, which may limit their potential use in developing drug formulations, with optimum bioavailability. One of the approaches to improve the solubility of a poorly water soluble drug and eventually its bioavailability is complexation with agents like humic acid (HA), fulvic acid (FA), β-cyclodextrin (β-CD), 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and caffeine (Caff). The current work emphasized at employing these agents to prepare different complexes and their in vitro/in vivo assessment. All the complexes evaluated for their complexation efficiency and authenticated by molecular modeling; conformational analysis, differential scanning calorimetry (DSC), X-ray diffraction (XRD), nuclear magnetic resonance (NMR) and mass spectroscopy. Furthermore, the complexes were assessed in an in vivo, rat vaginal model for their efficacy in treatment of vaginal candidiasis. Amongst the five tested complexes, fulvic acid-itraconazole complex yielded better solubility as well as in vivo efficacy and therefore may further be explored for developing a commercial formulation for treating vaginal candidiasis.
publisher Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400020
work_keys_str_mv AT mirzamohammadaamir invitroinvivoperformanceofdifferentcomplexesofitraconazoleusedinthetreatmentofvaginalcandidiasis
AT rahmanmohammadakhlaquer invitroinvivoperformanceofdifferentcomplexesofitraconazoleusedinthetreatmentofvaginalcandidiasis
AT talegaonkarsushama invitroinvivoperformanceofdifferentcomplexesofitraconazoleusedinthetreatmentofvaginalcandidiasis
AT iqbalzeenat invitroinvivoperformanceofdifferentcomplexesofitraconazoleusedinthetreatmentofvaginalcandidiasis
_version_ 1756437755483652096